Jason K. Molitoris

Dr. Jason K. Molitoris serves as Associate Professor and UMMC Medical Director in the Department of Radiation Oncology at the University of Maryland, based at the Marlene and Stewart Greenebaum Comprehensive Cancer Center. His clinical expertise spans genitourinary, gastrointestinal, central nervous system, and hematologic malignancies, with a focus on implementing advanced radiation technologies to optimize treatment efficacy and minimize side effects.

His educational background includes:

• Bachelor of Science in Biology, Summa cum laude, Phi Beta Kappa, The College of William and Mary
• MD/PhD through Medical Scientist Training Program, Case Western Reserve University School of Medicine (Alpha Omega Alpha)
• Internal Medicine Internship, Greater Baltimore Medical Center
• Radiation Oncology Residency and Chief Residency, University of Maryland Medical Center

Dr. Molitoris' research integrates basic science (cell death mechanisms in leukemia/lymphoma) with clinical applications of proton therapy, brachytherapy, and hyperthermia. His work emphasizes novel radiosensitization approaches, clinical trial development, and translational studies to improve outcomes in prostate, gastrointestinal, and CNS cancers while reducing treatment toxicity.

Analysis of his 15 most recent publications reveals a strong clinical outcomes focus across brain metastases, lung, breast, and prostate cancers. His work frequently utilizes multi-institutional collaborations and national databases to evaluate prognostic factors, treatment patterns, and advanced technologies like proton therapy, with consistent emphasis on balancing efficacy with quality-of-life preservation.

His awards include:

• Lynn Sage Breast Cancer Symposium Scholar Award
• RSNA Roentgen Resident/Fellow Research Award
• International Congress for Hyperthermic Oncology New Investigator Travel Award
• ASCO/AACR Research Fellow designation
• American Radium Society Travel Grant Award
• ASTRO Advocacy Day Travel Grant
• H.E.R.O. Award nomination
• University of Maryland Chief Resident distinction

Dr. Molitoris actively develops clinical trials through AACR/ASCO workshops and mentors residents, though specific grant details and student advisees aren't documented. His national presentations reflect leadership in radiation oncology innovation, particularly in thermal therapy and proton applications.

He operates within the Marlene and Stewart Greenebaum Comprehensive Cancer Center ecosystem, collaborating with multidisciplinary teams across the Maryland Proton Treatment Center and leveraging institutional resources for translational research in advanced radiation modalities.